Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Goktas, Zeynep ^a   Owens, Shannon ^a   Boylan, Mallory ^a   Syn, David ^b   Shen, Chwan Li ^c   Reed, Debra B ^a   San Francisco, Susan ^a   Wang, Shu ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; LIVER; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; PHYSIOLOGY;

ADIPOSE TISSUE; ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; LIVER; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY, MORBID; ORGAN SPECIFICITY; RETINOL-BINDING PROTEINS, PLASMA; SERPINS;

EID: 84893841593     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/861496     Document Type: Article

References (36)

1. Boden G., Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation? Diabetes 2009 58 3 518 519 2-s2.0-62749104401 10.2337/db08-1746
2. Darimont C., Avanti O., Blancher F., Wagniere S., Mansourian R., Zbinden I., Leone-Vautravers P., Fuerholz A., Giusti V., Macé K., Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. International Journal of Obesity 2008 32 1 112 120 2-s2.0-38149044024 10.1038/sj.ijo.0803688
3. Caruso C., Balistreri C. R., Candore G., The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators of Inflammation 2010 2010 19 2-s2.0-77955404414 10.1155/2010/802078 802078
4. Thompson A. M., Zhang Y., Tong W., Xu T., Chen J., Zhao L., Kelly T. N., Chen C.-S., Bazzano L. A., He J., Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. International Journal of Cardiology 2011 150 3 247 252 2-s2.0-79960558921 10.1016/j.ijcard.2010.04.011
5. Wang Z., Nakayama T., Inflammation, a link between obesity and cardiovascular disease. Mediators of Inflammation 2010 2010 17 2-s2.0-77956869772 10.1155/2010/535918 535918
6. Qasim A., Mehta N. N., Tadesse M. G., Wolfe M. L., Rhodes T., Girman C., Reilly M. P., Adipokines, insulin resistance, and coronary artery calcification. (Pubitemid 351915780)
7. Stofkova A., Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocrine Regulations 2010 44 1 25 36 2-s2.0-77955907509 10.4149/endo-2010-01-25
8. Toruner F., Altinova A. E., Akturk M., Kaya M., Arslan E., Bukan N., Kan E., Yetkin I., Arslan M., The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Research and Clinical Practice 2011 91 2 203 207 2-s2.0-79952042299 10.1016/j.diabres.2010.11.011
9. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005 307 5708 426 430 2-s2.0-19944433652 10.1126/science.1097243 (Pubitemid 40139988)
10. Tokunaga A., Miura A., Okauchi Y., Segawa K., Fukuhara A., Okita K., Takahashi M., Funahashi T., Miyagawa J.-I., Shimomura I., Yamagata K., The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects. Endocrine Journal 2008 55 1 205 212 2-s2.0-42049101839 10.1507/endocrj.K07E-039 (Pubitemid 351520199)
11. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937 (Pubitemid 44453463)
12. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Erratum (Retracted article): visfatin: a protein secreted by visceral fat that mimics the effects of insulin (Science). Science 2007 318 5850, article 565 2-s2.0-35548934694
13. Palin M.-F., Labrecque B., Beaudry D., Mayhue M., Bordignon V., Murphy B. D., Visfatin expression is not associated with adipose tissue abundance in the porcine model. Domestic Animal Endocrinology 2008 35 1 58 73 2-s2.0-44649103990 10.1016/j.domaniend.2008.01.008
14. Retnakaran R., Youn B.-S., Liu Y., Hanley A. J. G., Lee N. S., Park J. W., Song E. S., Vu V., Kim W., Tungtrongchitr R., Havel P. J., Swarbrick M. M., Shaw C., Sweeney G., Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study. Clinical Endocrinology 2008 69 6 885 893 2-s2.0-55949117816 10.1111/j.1365-2265.2008.03264.x
15. Sandeep S., Velmurugan K., Deepa R., Mohan V., Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 2007 56 4 565 570 2-s2.0-33947264366 10.1016/j.metabol.2006.12.005 (Pubitemid 46427855)
16. Fernández-Real J. M., Moreno J. M., Chico B., López-Bermejo A., Ricart W., Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007 30 3 616 621 2-s2.0-33847629715 10.2337/dc06-1581 (Pubitemid 46354343)
17. Lee J. A., Park H. S., Song Y. S., Jang Y. J., Kim J.-H., Lee Y. J., Heo Y.-S., Relationship between vaspin gene expression and abdominal fat distribution of Korean women. Endocrine Journal 2011 58 8 639 646 2-s2.0-80052582934 10.1507/endocrj.K11E-073
18. Wada J., Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opinion on Investigational Drugs 2008 17 3 327 333 2-s2.0-40949151070 10.1517/13543784.17.3.327 (Pubitemid 351578185)
19. Ye Y., Hou X.-H., Pan X.-P., Lu J.-X., Jia W.-P., Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chinese Medical Journal 2009 122 21 2530 2533 2-s2.0-73449085869 10.3760/cma.j.issn.0366-6999.2009.21.002
20. Kempf K., Rose B., Illig T., Rathmann W., Strassburger K., Thorand B., Meisinger C., Wichmann H.-E., Herder C., Vollmert C., Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Experimental and Clinical Endocrinology and Diabetes 2010 118 3 184 189 2-s2.0-77949511113 10.1055/s-2008-1081499
21. Martos-Moreno G. Á., Kratzsch J., Körner A., Barrios V., Hawkins F., Kiess W., Argente J., Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. International Journal of Obesity 2011 35 10 1355 1362 2-s2.0-80053970864 10.1038/ijo.2010.280
22. Esteve E., Ricart W., Fernández-Real J. M., Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes care 2009 32 2 S362 S367 2-s2.0-75549083100
23. Wolf G., Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutrition Reviews 2007 65 5 251 256 2-s2.0-34347208708 10.1301/nr.2007.may.251-256 (Pubitemid 351804369)
24. Graham T. E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T. P., Henry R. R., Wason C. J., Oberbach A., Jansson P.-A., Smith U., Kahn B. B., Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. The New England Journal of Medicine 2006 354 24 2552 2563 2-s2.0-33745095399 10.1056/NEJMoa054862 (Pubitemid 43882351)
25. Yang Q., Graham T. E., Mody N., Preitner F., Peroni O. D., Zabolotny J. M., Kotani K., Quadro L., Kahn B. B., Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005 436 7049 356 362 2-s2.0-22944434929 10.1038/nature03711 (Pubitemid 41065039)
26. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I., Cloning and characterization of the cDNA encoding a novel human pre-B- cell colony-enhancing factor. Molecular and Cellular Biology 1994 14 2 1431 1437 2-s2.0-0027958452
27. Kukla M., Mazur W., Bułdak R. J., Zwirska-Korczala K., Potential role of leptin, adiponectin and three novel adipokines-visfatin, chemerin and vaspin-in chronic hepatitis. Molecular Medicine 2011 17 11-12 1397 1410 2-s2.0-82855168116 10.2119/molmed.2010.00105
28. Alghasham A. A., Barakat Y. A., Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy. Saudi Medical Journal 2008 29 2 185 192 2-s2.0-40749154413 (Pubitemid 351385116)
29. Dogru T., Sonmez A., Tasci I., Bozoglu E., Yilmaz M. I., Genc H., Erdem G., Gok M., Bingol N., Kilic S., Ozgurtas T., Bingol S., Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Research and Clinical Practice 2007 76 1 24 29 2-s2.0-33846930861 10.1016/j.diabres.2006.07.031 (Pubitemid 46240362)
30. Sun G., Bishop J., Khalili S., Vasdev S., Gill V., Pace D., Fitzpatrick D., Randell E., Xie Y.-G., Zhang H., Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. American Journal of Clinical Nutrition 2007 85 2 399 404 2-s2.0-33846857186 (Pubitemid 46220940)
31. von Eynatten M., Humpert P. M., Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Review of Molecular Diagnostics 2008 8 3 289 299 2-s2.0-44249089099 10.1586/14737159.8.3.289 (Pubitemid 351724708)
32. Klöting N., Berndt J., Kralisch S., Kovacs P., Fasshauer M., Schön M. R., Stumvoll M., Blüher M., Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochemical and Biophysical Research Communications 2006 339 1 430 436 2-s2.0-28144450841 10.1016/j.bbrc.2005.11.039 (Pubitemid 41697566)
33. El-Mesallamy H. O., Kassem D. H., El-Demerdash E., Amin A. I., Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011 60 1 63 70 2-s2.0-78649906890 10.1016/j.metabol.2010.04.008
34. Li Q., Chen R., Moriya J., Yamakawa J., Sumino H., Kanda T., Takahashi T., A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. Journal of International Medical Research 2008 36 4 625 629 2-s2.0-52049110080
35. Youn B.-S., Klöting N., Kratzsch J., Lee N., Park J. W., Song E.-S., Ruschke K., Oberbach A., Fasshauer M., Stumvoll M., Blüher M., Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 57 2 372 377 2-s2.0-40749155505 10.2337/db07-1045
36. Chang H. M., Lee H. J., Park H. S., Kang J. H., Kim K. S., Song Y. S., Jang Y. J., Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity 2010 18 11 2105 2110 2-s2.0-78049258257 10.1038/oby.2010.60